PRESTIGIOUS MEDICAL AND PUBLIC HEALTH JOURNAL “THE LANCET REGIONAL HEALTH” PUBLISHES PIVOTAL PHASE 3 CLINICAL STUDY ON
MIQNAF^® (NAFITHROMYCIN) – A LANDMARK FOR INDIA’S ANTIBIOTIC INNOVATION